Please assess the completion status of the following clinical trial:

Trial Title: A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adults age 19 and over~2. Clinical diagnosis of genital warts requiring treatment based on clinician evaluation~3. Fluency in English~4. Available within four days of the intended 8 week follow-up visit~Exclusion Criteria:~1. Individuals under the age of 19~2. Pregnant women~3. Known contraindication to zinc Signs of copper/iron deficiency which include anemia and neutropenia which are characterized by tiredness, fatigue and light headedness.~4. Diseases that alter zinc metabolism or absorption eg. type II diabetes mellitus, Crohn's disease, chronic leg ulcers~5. Clients who are currently taking zinc for therapeutic purposes or have taken zinc in the last two months for therapeutic purposes~6. Clients who have received standard of care treatment for their warts in the past month

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Oral Zinc (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).